Search Results - "Kockler, L"

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Quality-of-life findings from a randomised phase-III study of XELOX vs FOLFOX-6 in metastatic colorectal cancer

    Quality-of-life findings from a randomised phase-III study of XELOX vs FOLFOX-6 in metastatic colorectal cancer by Conroy, T, Hebbar, M, Bennouna, J, Ducreux, M, Ychou, M, Llédo, G, Adenis, A, Faroux, R, Rebischung, C, Kockler, L, Douillard, J Y

    Published in British journal of cancer (05-01-2010)
    “…Background: A phase-III trial showed the non-inferiority of oral capecitabine plus oxaliplatin (XELOX) vs 5-fluorouracil/leucovorin plus oxaliplatin (FOLFOX-6)…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    Abstract P2-16-05: BEVERLY2, a Phase II Study Evaluating Bevacizumab (BEV) Combined with Chemotherapy (CT) and Trastuzumab (H) as Neoadjuvant Therapy for HER2-Positive Inflammatory Breast Cancer (IBC): First Efficacy Results

    Abstract P2-16-05: BEVERLY2, a Phase II Study Evaluating Bevacizumab (BEV) Combined with Chemotherapy (CT) and Trastuzumab (H) as Neoadjuvant Therapy for HER2-Positive Inflammatory Breast Cancer (IBC): First Efficacy Results by Viens, P, Pierga, J-Y, Petit, T, Delozier, T, Ferrero, J-M, Campone, M, Gligorov, J, Lerebours, F, Roche, H, Kockler, L, Bachelot, T, Charafe-Jauffrete, E.

    Published in Cancer research (Chicago, Ill.) (15-12-2010)
    “…Abstract Background: The efficacy of first-line CT for HER2-negative metastatic breast cancer is significantly improved by combining CT with BEV, as shown in…”
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: